Literature DB >> 23194468

The cost of providing primary health-care services from a needle and syringe program: a case study.

M Mofizul Islam1, Marian Shanahan, Libby Topp, Katherine M Conigrave, Ann White, Carolyn A Day.   

Abstract

INTRODUCTION AND AIMS: Targeted primary health-care services for injecting drug users have been established in several countries to reduce barriers to health care, subsequent poor health outcomes and the considerable costs of emergency treatment. The long-term sustainability of such services depends on the resources required and the coverage provided. This study assesses the additional cost required to operate a nurse-led primary health care in an existing needle syringe program setting, estimates the costs per occasion of service and identifies key factors influencing improved service utilisation. DESIGN AND METHODS: Using standard costing methods and the funder perspective, this study estimates costs using the 'ingredients' approach where the costs of inputs are based on quantities and unit prices (the ingredients).
RESULTS: During the 2009-2010 fiscal year, the primary health-care clinic provided 1252 occasions of service to 220 individuals, who each made an average of 3.9 presentations. A total cost of AU$250,626 was incurred, 69% of which was for personnel and 22% for pathology. During the study period the average cost per occasion of service was AU$199.96, which could be as low as AU$93.32 if the clinic reached its full utilisation level. DISCUSSION AND
CONCLUSIONS: Although the average number of presentations per client was satisfactory, the clinic was underutilised during the study period. Proactive engagement of clients at the needle syringe program shopfront and an increased range of services offered by the clinic may help to attract more clients.
© 2012 Australasian Professional Society on Alcohol and other Drugs.

Mesh:

Year:  2012        PMID: 23194468     DOI: 10.1111/dar.12019

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  2 in total

1.  Health care utilization and the cost of posttraumatic acute respiratory distress syndrome care.

Authors:  Anamaria J Robles; Lucy Z Kornblith; Carolyn M Hendrickson; Benjamin M Howard; Amanda S Conroy; Farzad Moazed; Carolyn S Calfee; Mitchell J Cohen; Rachael A Callcut
Journal:  J Trauma Acute Care Surg       Date:  2018-07       Impact factor: 3.313

2.  Harm Minimisation Drug Policy Implementation Qualities: Their Efficacy with Australian Needle and Syringe Program Providers and People Who Inject Drugs.

Authors:  Danielle Resiak; Elias Mpofu; Roderick Rothwell
Journal:  Healthcare (Basel)       Date:  2022-04-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.